EpiPen recall: supplier announces recall of adrenaline shots

EpiPen recall: supplier announces recall of adrenaline shots

PHARMACEUTICAL company Alphapharm has recalled a batch of EpiPen 300 microgram (µg) Adrenaline Injection Syringe Auto-Injectors, used for the treatment of anaphylaxis.

There is a potential the devices may contain a defective part that could cause failure to activate, or require increased force to activate.

MORE: Mirrabooka Extreme Ice Arena a lightning rod for disaster

MORE: Crowds expected to flock to Elizabeth Quay for Buddha’s Birthday celebrations

MORE: Clubs WA comes out in support of embattled bowls club

The failure of the auto-injector may result in patients not receiving the required dose of adrenaline, which could be life threatening.

Consumers should check if they have a 300 µg EpiPen (yellow carton and label) and if so, check the batch number and expiry.

The batch number and expiry can be found on the label of the pen or on the end of the carton.

If the EpiPen 300µg has the following batch numbers: 5FA665, 5FA6651, 5FA6652 or 5FA6653 and an expiry of Apr 17, it needs to be replaced with a new one as soon as possible.

Consumers should return it to their pharmacist who will replace the EpiPen 300µg from the affected batch with an EpiPen 300µg from a different batch at no cost.